The reactivity of sera from chagasic patients against different fragments of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, suggests the presence of defined antigenic and catalytic domains

Immunol Lett. 1993 Feb;35(2):191-6. doi: 10.1016/0165-2478(93)90090-o.

Abstract

Three fragments of cruzipain, expressed separately in bacterial vectors, were used to detect antibodies in sera from patients with chronic Chagas' disease. Most antibodies directed against the enzyme were found to react with the C-terminal extension, thus suggesting the presence of immunodominant B-cell epitopes within this protein domain. Immunoprecipitation with these antibodies did not impair enzyme activity. It is suggested that cruzipain consists of an enzymatic domain and a non-enzymatic, immunodominant domain, which corresponds to the C-terminal extension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies
  • Antibodies, Protozoan / blood*
  • B-Lymphocytes / immunology
  • Binding Sites / immunology
  • Chagas Disease / immunology*
  • Cysteine Endopeptidases / analysis
  • Cysteine Endopeptidases / immunology*
  • Epitopes / immunology
  • Humans
  • Peptide Fragments
  • Protozoan Proteins
  • Trypanosoma cruzi / enzymology*
  • Trypanosoma cruzi / immunology

Substances

  • Antibodies
  • Antibodies, Protozoan
  • Epitopes
  • Peptide Fragments
  • Protozoan Proteins
  • Cysteine Endopeptidases
  • cruzipain